TY - JOUR T1 - Simulating the Impacts of Interregional Mobility Restriction on the Spatial Spread of COVID-19 in Japan JF - medRxiv DO - 10.1101/2020.12.28.20248926 SP - 2020.12.28.20248926 AU - Keisuke Kondo Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/02/2020.12.28.20248926.abstract N2 - This study develops a spatial Susceptible–Exposed–Infectious–Recovered (SEIR) model that analyzes the effect of interregional mobility on the spatial spread of the coronavirus disease 2019 (COVID-19) outbreak in Japan. National and local governments have requested that residents refrain from traveling between 47 prefectures during the state of emergency. However, the extent to which restricting the interregional mobility prevents infection expansion has not been elucidated. Our spatial SEIR model describes the spatial spread pattern of COVID-19 when people commute to a prefecture where they work or study during the daytime and return to their residential prefecture at night. We assume that people are exposed to infection risk during their daytime activities. According to our simulation results, interregional mobility restriction can prevent geographical expansion of the infection. However, in prefectures with many infectious individuals, residents are exposed to higher infection risk when their mobility is restricted. Our simulation results also show that interregional mobility restriction plays a limited role in reducing the national total number of infected individuals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received no external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe R code and data for this study are available on GitHub. (https://github.com/keisukekondokk/spatial-seir) The numerical simulation results in this study are provided on the web app "COVID-19 Simulator in Japan.” (https://keisuke-kondo.shinyapps.io/covid19-simulator-japan/) https://github.com/keisukekondokk/spatial-seir https://keisuke-kondo.shinyapps.io/covid19-simulator-japan/ ER -